BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10702910)

  • 1. Synthesis and purification of a deleted human growth hormone, hGH delta 135-146: sensitivity to plasmin cleavage and in vitro and in vivo bioactivities.
    Alam KS; Fujikawa T; Yoshizato H; Tanaka M; Nakashima K
    J Biotechnol; 2000 Feb; 78(1):49-59. PubMed ID: 10702910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
    Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
    Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
    Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of a mutant human growth hormone that is resistant to proteolytic cleavage by thrombin, plasmin and human plasma in vitro.
    Alam KS; Morimoto M; Yoshizato H; Fujikawa T; Furukawa K; Tanaka M; Nakashima K
    J Biotechnol; 1998 Oct; 65(2-3):183-90. PubMed ID: 9828461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
    Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
    Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
    Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
    Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
    Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
    Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
    Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
    J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
    Cameron CM; Kostyo JL; Adamafio NA; Brostedt P; Roos P; Skottner A; Forsman A; Fryklund L; Skoog B
    Endocrinology; 1988 Feb; 122(2):471-4. PubMed ID: 3276499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of authentic 20-kDa human growth hormone (20K hGH) in Escherichia coli and properties of the purified product.
    Uchida H; Naito N; Asada N; Wada M; Ikeda M; Kobayashi H; Asanagi M; Mori K; Fujita Y; Konda K; Kusuhara N; Kamioka T; Nakashima K; Honjo M
    J Biotechnol; 1997 Jun; 55(2):101-12. PubMed ID: 9232032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
    Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
    Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver.
    Ooi GT; Cohen FJ; Tseng LY; Rechler MM; Boisclair YR
    Mol Endocrinol; 1997 Jun; 11(7):997-1007. PubMed ID: 9178759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
    Takahashi S; Shiga Y; Satozawa N; Hayakawa M
    Growth Horm IGF Res; 2001 Apr; 11(2):110-6. PubMed ID: 11472077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization.
    Uchida H; Banba S; Wada M; Matsumoto K; Ikeda M; Naito N; Tanaka E; Honjo M
    J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone.
    Hashimoto Y; Ikeda I; Ikeda M; Takahashi Y; Hosaka M; Uchida H; Kono N; Fukui H; Makino T; Honjo M
    J Immunol Methods; 1998 Dec; 221(1-2):77-85. PubMed ID: 9894899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.
    Bozzola M; Zecca M; Locatelli F; Radetti G; Pagani S; Autelli M; Tatò L; Chatelain P
    J Endocrinol Invest; 1998 Dec; 21(11):765-70. PubMed ID: 9972677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteo-anabolic effects of human growth hormone with 22K- and 20K Daltons on human osteoblast-like cells.
    Wang DS; Sato K; Demura H; Kato Y; Maruo N; Miyachi Y
    Endocr J; 1999 Feb; 46(1):125-32. PubMed ID: 10426576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.